Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

874
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
874
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

631
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
631
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

480
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
480
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

1.0K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.0K
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

397
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
397

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From promise to practice: why HRMS has yet to fully revolutionize forensic toxicology.

Journal of analytical toxicology·2025
Same author

Trends in central/peripheral ratio of fentanyl in Harris County, TX, and Orange County, CA, from 2009 to 2020.

Journal of analytical toxicology·2024
Same author

Mitragynine in the Orange County DUID population.

Journal of analytical toxicology·2023
Same author

A Two-Year Review of Fentanyl in Driving under the Influence and Postmortem Cases in Orange County, CA, USA.

Journal of analytical toxicology·2022
Same author

Cannabinoid Stability in Antemortem and Postmortem Blood.

Journal of analytical toxicology·2019
Same author

The Trouble With Kratom: Analytical and Interpretative Issues Involving Mitragynine.

Journal of analytical toxicology·2019

Related Experiment Video

Updated: Sep 18, 2025

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
07:56

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts

Published on: January 29, 2018

17.7K

Tizanidine in postmortem forensic cases.

Laura Friederich1, Dani Mata2, Sandra Bishop-Freeman1,3

  • 1Department of Health and Human Services, Division of Public Health, North Carolina Office of Chief Medical Examiner, Raleigh, NC 27607, United States.

Journal of Analytical Toxicology
|June 27, 2025
PubMed
Summary

Forensic toxicologists should be aware of tizanidine, an alpha-2 adrenergic receptor agonist, due to its potential for toxicity. This study reviews postmortem cases to help differentiate therapeutic from lethal tizanidine concentrations.

More Related Videos

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.4K
Image Rendering Techniques in Postmortem Computed Tomography: Evaluation of Biological Health and Profile in Stranded Cetaceans
12:32

Image Rendering Techniques in Postmortem Computed Tomography: Evaluation of Biological Health and Profile in Stranded Cetaceans

Published on: September 27, 2020

8.8K

Related Experiment Videos

Last Updated: Sep 18, 2025

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
07:56

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts

Published on: January 29, 2018

17.7K
Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.4K
Image Rendering Techniques in Postmortem Computed Tomography: Evaluation of Biological Health and Profile in Stranded Cetaceans
12:32

Image Rendering Techniques in Postmortem Computed Tomography: Evaluation of Biological Health and Profile in Stranded Cetaceans

Published on: September 27, 2020

8.8K

Area of Science:

  • Forensic Toxicology
  • Pharmacology

Background:

  • Alpha-2 adrenergic receptor agonists, like tizanidine, are used for various medical conditions.
  • Tizanidine is less commonly identified in forensic toxicology, with limited data on its antemortem and postmortem concentrations.
  • CYP1A2 inhibitors can increase tizanidine levels, raising toxicity risk, and imidazoline receptor activity contributes to its effects.

Purpose of the Study:

  • To analyze postmortem tizanidine concentrations in 18 cases.
  • To establish a forensic toxicological profile for tizanidine.
  • To aid in distinguishing therapeutic from toxic/lethal concentrations in postmortem investigations.

Main Methods:

  • Review of 18 postmortem cases involving tizanidine.
  • Categorization of cases by pathologists into "Suicide," "Accident," and "Incidental."
  • Analysis and comparison of tizanidine concentrations across case categories.

Main Results:

  • Suicide cases (N=8) had a mean tizanidine concentration of 6.2 mg/L (median 0.77 mg/L).
  • Accident cases (N=4) had a mean tizanidine concentration of 0.86 mg/L (median 0.89 mg/L).
  • Incidental cases (N=6) had a mean tizanidine concentration of 0.35 mg/L (median 0.035 mg/L).

Conclusions:

  • Tizanidine concentrations vary significantly based on manner of death.
  • This data can assist forensic toxicologists in interpreting postmortem tizanidine levels.
  • Case investigation details are crucial for determining cause and manner of death.